TK
Thomas K Equels bought $7K of AIM stock
Thomas K Equels, CEO & President of AIM ImmunoTech Inc. (AIM), bought 50,000 shares of AIM stock worth $7K, per an SEC Form 4 filed Nov 20, 2026.
It was an open-market purchase.
The trade happened on Nov 19, 2026, 1 day before it was made public.
AIM has moved +0.0% since the trade date, from $0.12 to $0.12 (Nov 19, 2026 close).
- Traded
- Nov 19, 2026
- Disclosed
- Nov 20, 2026
- Filing delay
- 1 day
- Price since
- +0.0%
- Role
- CEO & President
- Source
- SEC Form 4